Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries-Reference-Cited by-同舟云学术

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries

Published:2018-03-21 Issue:1 Volume:6 Page:55-72
ISSN:2169-575X
Container-title:Global Health: Science and Practice
language:en
Short-container-title:Glob Health Sci Pract

Author:

Stout Anna,Wood Siri,Barigye George,Kaboré Alain,Siddo Daouda,Ndione Ida

Publisher

Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs

Subject

General Medicine

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical development and pharmacokinetic assessment in macaques of a multipurpose long-acting injectable suspension containing medroxyprogesterone acetate for contraception and rilpivirine for HIV prevention;Journal of Drug Delivery Science and Technology;2023-08

2. An Evaluation of an Enhanced Model of Integrating Family Planning Into HIV Treatment Services in Zambia, April 2018–June 2019;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-02-01

3. Missed opportunity for self-injectable contraception awareness and adoption: Insights from client exit interviews in Uganda and Nigeria;Contraception: X;2023

4. What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device;Global Health: Science and Practice;2022-10-06

5. Provision of injectable contraceptives by community health workers in sub-Saharan Africa: a systematic review of safety, acceptability and effectiveness;Human Resources for Health;2022-09-05